BRITTNEY PUGH: Open Payments
NPI 1679017230 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,673 in 137 payments from 24 companies in 2025. Trend: 2023 $1,151 · 2024 $1,371 · 2025 $2,673
Food & beverage: $2,573Education: $100
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 11 | $401 |
| ABBVIE INC. | 29 | $329 |
| Axsome Therapeutics, Inc. | 9 | $257 |
| GlaxoSmithKline, LLC. | 14 | $224 |
| Lilly USA, LLC | 14 | $209 |
| AstraZeneca Pharmaceuticals LP | 9 | $193 |
| Astellas Pharma US Inc | 10 | $186 |
| Abbott Laboratories | 5 | $113 |
| PFIZER INC. | 5 | $111 |
| Exact Sciences Corporation | 5 | $106 |
Products named: Korlym, Auvelity, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, FREESTYLE LIBRE 3, FARXIGA, UBRELVY.
Industry payments across TX — which companies pay providers there.
